About: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) article scientifique publié en 1998 (fr) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1998 (ast) artikull shkencor i botuar më 01 shkurt 1998 (sq) scientific article published on 01 February 1998 (en)
publication date	wds:Q74106097-C77017CF-DAAC-401C-873C-5662CC204531
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74106097-0777836F-CBBB-4D05-B1CA-5C5E75B9509E wds:Q74106097-2E6682FF-A990-4887-8ADF-E78B76422C22 wds:Q74106097-311567EE-A89E-4595-BCEA-2BA9387C70F1 wds:Q74106097-32412009-0C54-47FD-99F1-91782D78E5B8 wds:Q74106097-37B525B1-8758-4499-A006-4549C01027FA wds:Q74106097-4C1F5E7B-DB1E-4A83-B730-937CD428767F wds:Q74106097-4EC7C6F8-167F-4B38-95F0-2767237223C7 wds:Q74106097-7BE1BFCB-AF74-4235-A3A3-429AB2A360E1 wds:Q74106097-800271AA-CB29-436C-B374-6FF86637845C wds:Q74106097-94A47839-8ED2-49FB-876B-3F614D05A7C7 wds:Q74106097-94E46CB0-36E1-46E1-95A9-698596C31562 wds:Q74106097-DB08D9E0-8C97-40D6-A291-5CCD33B0518D wds:Q74106097-DE8BF42A-BD83-4E3F-87B0-D4DACC217680 wds:Q74106097-F0691D8F-2E82-40D1-9003-9D68FB576A03 wds:Q74106097-F1266C98-8E57-464C-80CD-333AECD19F2B
author name string	Samuel S Slavin S Nagler A Or R Eldor A Aker M Cividalli G Brautbar C Kapelushnik Y Kirschbaum M Naparstek E Varadi G Ben-Tal O Ackerstein A Amar A
rdfs:label	Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (en) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (nl) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (sq)
skos:prefLabel	Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (en) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (nl) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (sq)
name	Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (en) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (nl) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (sq)
title	wds:Q74106097-D2853927-01B8-43D0-9DD5-FBA6D08190AE
title	Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases (en)
page(s)	wds:Q74106097-7CEC032D-44BB-40C7-8FA1-EBE9C29405CC
page(s)	756-763
instance of	wds:Q74106097-5E9DD31B-E280-4513-B23A-91BE5E9419A2
instance of	scholarly article
main subject	wds:Q74106097-41394A2F-140E-4E13-99D5-EC446758F3C9
main subject	stem cell transplantation
PubMed ID	wds:Q74106097-B5EE66AA-E094-449C-B4BB-90B224281A0C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9446633
PubMed ID	9446633
published in	wds:Q74106097-3478FC4C-3798-46A0-AAF6-AD994D09141A
published in	Blood
issue	wds:Q74106097-A5C2EC4E-6875-433A-821C-41E27E842BAC
volume	wds:Q74106097-42E230BF-2811-4CA7-9C77-3E29C3AE545E
issue	3
volume	91
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74106097
is cites work of	The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the Europea Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning Acute graft versus host disease Outcome of transplantation for myelofibrosis Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review Mesenchymal stromal cells: a new tool against graft-versus-host disease? The risk of cytomegalovirus infection in non-myeloablative peripheral stem cell transplantation compared with conventional bone marrow transplantation Evidence for ineffective erythropoiesis in severe sickle cell disease Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation Hematopoietic cell transplantation for treatment of primary immune deficiencies Gut toxicity during hemopoietic stem cell transplantation may predict acute graft-versus-host disease severity in patients Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation Allogeneic hematopoietic cell transplantation: the state of the art Defining the intensity of conditioning regimens: working definitions Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M Features of Microsystems for Cultivation and Characterization of Stem Cells with the Aim of Regenerative Therapy CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002). Stem cell transplantation The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study Group Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software